D-0474-2017 Class II Terminated
FDA drug recall D-0474-2017 was initiated by Aurobindo Pharma USA Inc on Dec 22, 2016 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules. The recall status is terminated (terminated Mar 19, 2019). Affected quantity: 47,040 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 22, 2017
- Initiation Date
- Dec 22, 2016
- Termination Date
- Mar 19, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 47,040 bottles
Product description
Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30
Reason for recall
Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
Distribution pattern
Nationwide in the US
Code information
Lot #: VI3716010-A, Exp. 04/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0474-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026